[Blood pressure control in Europe is worse than in the USA].
Minutolo
Roberto
R
Cattedra di Nefrologia, Seconda Università degli Studi, Napoli. roberto.minutolo@unina2.it
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D005060:Europe; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D007558:Italy; D017410:Practice Guidelines as Topic; D014481:United States
D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents